- Cell Biology
- Product Type
- Research Area
- New Products
- About Tocris
- Contact Us
Ceramidases (EC 184.108.40.206) are a group of enzymes which catalyze the hydrolysis of ceramides to produce sphingosine, which subsequently undergoes phosphorylation to generate sphingosine-1-phosphate (S1P).
|Cat No||Product Name / Activity|
|Ceramidase inhibitor; antiproliferative|
|GPR55 agonist; ceramidase inhibitor|
Ceramidases (EC 220.127.116.11) are a group of enzymes which catalyze the hydrolysis of ceramides to produce sphingosine, which subsequently undergoes phosphorylation to generate sphingosine-1-phosphate (S1P). Ceramide and its downstream products, sphingosine and S1P, are bioactive lipids that mediate various cellular processes including cell growth arrest, differentiation and apoptosis.
The expression of ceramides increases in response to stressful stimuli, such as proapoptotic cytokines, cancer chemotherapeutic agents, UV and ionizing radiation, vitamins such as retinoic acid, and serum deprivation.
Members of the ceramidase enzyme family can be classified according to their substrate as well as their optimum pH for biological activity. Due to differences in substrate specificity between the ceramidases, cellular localization, tissue distribution and expression, several distinct physiological roles have been suggested for these enzymes. For example, upregulation of acid and neutral ceramidases is linked to cell proliferation and survival, whilst upregulation of alkaline ceramidases has divergent effects dependent on the enzyme subtype (Alkaline ceramidases 1, 2 or 3).
Tocris offers the following scientific literature for Ceramidases to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
There are two currently recognized forms of programmed cell death: apoptosis and necroptosis. This poster summarizes the signaling pathways involved in apoptosis, necroptosis and cell survival following death receptor activation, and highlights the influence of the molecular switch, cFLIP, on cell fate.
|Gene||Species||Gene Symbol||Gene Accession No.||Protein Accession No.|
|Alkaline ceramidase 1||Human||ACER1||NM_133492||Q8TDN7|
|Alkaline ceramidase 2||Human||ACER2||XM_294540||Q5QJU3|
|Alkaline ceramidase 3||Human||ACER3||NM_018367||Q9NUN7|
|N-acylsphingosine amidohydrolase (acid ceramidase) 1||Human||ASAH1||NM_004315||Q13510|
|N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2||Human||ASAH2||NM_019893||Q9NR71|
|N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2B||Human||ASAH2B||NM_001079516||P0C7U1|
|N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2C||Human||ASAH2C||NG_012763||P0C7U2|
|N-acylethanolamine acid amidase||Human||NAAA||NM_001042402||Q02083|
|Glucosidase, beta, acid||Human||GBA||NM_000157||P04062|
|Glucosidase, beta (bile acid) 2||Human||GBA2||NM_020944||Q9HCG7|